Cargando...
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
BACKGROUND: Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum inhibit...
Gardado en:
| Publicado en: | BMC Microbiol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683470/ https://ncbi.nlm.nih.gov/pubmed/31382897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-019-1558-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|